Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill

Posted by on February 8, 2022 7:41 am
Categories: US National Stories

Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.

Leave a Reply

Your email address will not be published.